Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)

Guidelines Detail: https://www.nccn.org/guidelines/guidelines-detail.

Stjepanovic N, Moreira L, Carneiro F, et al. Hereditary gastrointestinal cancers: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30:1558–71.

Article  CAS  PubMed  Google Scholar 

Genetics of Prostate Cancer (PDQ®)–Health Professional Version—NCI https://www.cancer.gov/types/prostate/hp/prostate-genetics-pdq.

Lung Cancer Statistics | How common is lung cancer? https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html. Accessed 12 Mar 2023.

Malvezzi M, Santucci C, Boffetta P, et al. European cancer mortality predictions for the year 2023 with focus on lung cancer. Ann Oncol. 2023;34:410–9.

Article  CAS  PubMed  Google Scholar 

Steuer CE, Jegede OA, Dahlberg SE, et al. Smoking behavior in patients with early-stage NSCLC: a report from ECOG-ACRIN 1505 trial. J Thorac Oncol. 2021;16:960–7.

Article  PubMed  PubMed Central  Google Scholar 

Malhotra J, Malvezzi M, Negri E, et al. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48:889–902.

Article  PubMed  Google Scholar 

Riudavets M, Garcia de Herreros M, Besse B, et al. Radon and lung cancer: current trends and future perspectives. Cancers. 2022;14:3142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

A New Pathway from Air Pollution to Lung Cancer in Non-Smokers https://dailyreporter.esmo.org/esmo-congress-2022/research-advances-in-the-last-months/a-pathway-from-air-pollution-to-lung-cancer-in-non-smokers-has-been-identified.

Benusiglio PR, Fallet V, Sanchis-Borja M, et al. Lung cancer is also a hereditary disease. Eur Respir Rev. 2021;30: 210045.

Article  PubMed  PubMed Central  Google Scholar 

Chang ET, Smedby KE, Hjalgrim H, et al. Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst. 2006;98:61–8.

Article  PubMed  Google Scholar 

Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292:1480–9.

Article  CAS  PubMed  Google Scholar 

Sorscher S, LoPiccolo J, Chen E, et al. Landscape of pathogenic germline variants in patients with lung cancer. JCO. 2022;40:388570–388570.

Article  Google Scholar 

Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9:59.

Article  PubMed  PubMed Central  Google Scholar 

Lashkarizadeh M, Lashkarizadeh M, Nikian M, et al. The expression of HER2/neu in patients with lung cancer and its associated factors. Clin Respir J. 2023;17:90–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tammemagi MC, Schmidt H, Martel S, et al. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian early detection of lung cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol. 2017;18:1523–31.

Article  PubMed  Google Scholar 

Cassidy A, Balsan J, Vesin A, et al. Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in Europe. Eur J Cancer. 2009;45:3047–53.

Article  PubMed  Google Scholar 

Gaur P, Bhattacharya S, Kant S, et al. Hospital-based study on demographic, hematological, and biochemical profile of lung cancer patients. J Cancer Res Ther. 2020;16:839–42.

Article  PubMed  Google Scholar 

Isla D, Felip E, Viñolas N, et al. Lung cancer in women with a family history of cancer: the Spanish female-specific database WORLD07. Anticancer Res. 2016;36:6647–53.

Article  PubMed  Google Scholar 

Gorlova OY, Zhang Y, Schabath MB, et al. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006;118:1798–804.

Article  CAS  PubMed  Google Scholar 

Chen Y, Li G, Lei Y, et al. Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer. Thorac Cancer. 2019;10:695–707.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zang R, Shi J-F, Lerut TE, et al. Ten-year trends of clinicopathologic features and surgical treatment of lung cancer in China. Ann Thorac Surg. 2020;109:389–95.

Article  PubMed  Google Scholar 

Tsugane S, Watanabe S, Sugimura H, et al. Smoking, occupation and family history in lung cancer patients under fifty years of age. Jpn J Clin Oncol. 1987;17:309–17.

CAS  PubMed  Google Scholar 

Chen K-Y, Hsiao C-F, Chang G-C, et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer. 2007;110:1768–75.

Article  CAS  PubMed  Google Scholar 

Titan AL, He H, Lui N, et al. The influence of hormone replacement therapy on lung cancer incidence and mortality. J Thorac Cardiovasc Surg. 2020;159:1546-1556.e4.

Article  PubMed  Google Scholar 

Jin K, Hung RJ, Thomas S, et al. Hormonal factors in association with lung cancer among Asian women: a pooled analysis from the international lung cancer consortium. Int J Cancer. 2021;148:2241–54.

Article  CAS  PubMed  Google Scholar 

Pathak A, Wenzlaff AS, Hyland PL, et al. Apoptosis-related single nucleotide polymorphisms and the risk of non-small cell lung cancer in women. J Cancer Ther Res. 2014;3:1.

Article  CAS  Google Scholar 

Lee Y, Jeon JH, Goh S-H, et al. The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma. Lung Cancer. 2019;136:15–22.

Article  PubMed  Google Scholar 

Osann KE. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res. 1991;51:4893–7.

CAS  PubMed  Google Scholar 

Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol. 2007;25:5785–92.

Article  PubMed  Google Scholar 

Tammemagi CM, Freedman MT, Church TR, et al. Factors associated with human small aggressive non small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2082–9.

Article  PubMed  Google Scholar 

Cote ML, Yoo W, Wenzlaff AS, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis. 2009;30:626–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong Y-S, Kang H-J, Kwak J-Y, et al. Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. J Prev Med Public Health. 2011;44:125–30.

Article  PubMed  Google Scholar 

Schwartz AG, Wenzlaff AS, Bock CH, et al. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011;32:312–7.

Article  CAS  PubMed  Google Scholar 

Sin DD, Tammemagi CM, Lam S, et al. Pro-surfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol. 2013;31:4536–43.

Article  PubMed  PubMed Central  Google Scholar 

Xu P, Liu L, Wang J, et al. Genetic variation in BCL2 3’-UTR was associated with lung cancer risk and prognosis in male Chinese population. PLoS ONE. 2013;8: e72197.

Article  CAS 

留言 (0)

沒有登入
gif